Anti-MDA5 antibody-positive dermatomyositis (MDA5+ DM), a distinct subtype of idiopathic inflammatory myopathies (IIM), is significantly associated with interstitial lung disease (ILD), particularly the rapidly progressive interstitial lung disease (RP-ILD). The gene discussed is IFIH1; the disease is interstitial lung disease.